OnKure Inc.

---

Boulder’s OnKure goes public with merger; key drug trial underway

 October 7, 2024 2:55:33 pm

---

OnKure hires ex-Pfizer research leader as chief scientific officer

 July 26, 2024 12:24:06 pm

---

OnKure names Rogan Nunn as general counsel

 July 9, 2024 5:16:13 am

---

With first drug trial underway, OnKure inks merger with Reneo Pharma to go public

 May 13, 2024 2:42:24 pm

---

OnKure hires chief medical officer as drug trials loom

 February 20, 2024 2:50:02 pm

---

OnKure’s lead cancer-drug candidate clears FDA hurdle

 January 4, 2024 6:33:16 pm

---

OnKure closes Series C at $54M

 May 23, 2023 6:12:29 am

---

OnKure aims for $60M in new funding round

 April 3, 2023 3:24:52 pm

---

OnKure Therapeutics hires clinical development leader

 December 12, 2022 1:50:39 pm

---

OnKure Therapeutics appoints new vice president

 June 27, 2022 2:58:36 pm

Next Page »